Methotrexate used as a steroid-sparing agent in non-renal chronic Henoch-Schönlein purpura

Academic Article

Abstract

  • Henoch-Schönlein purpura (HSP) is the most common form of systemic vasculitis in childhood and a small percentage of children develop a chronic form of the disease that often requires prolonged corticosteroid therapy. A detailed case description of a child with non-renal chronic HSP treated with methotrexate to allow for tapering of corticosteroids is presented. This represents the first report of methotrexate use in the treatment of chronic HSP.
  • Author List

  • Rettig P; Cron RQ
  • Start Page

  • 767
  • End Page

  • 769
  • Volume

  • 21
  • Issue

  • 6